相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis
Tao Wei et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection
Qingfeng Song et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma
Yutaka Midorikawa et al.
WORLD JOURNAL OF SURGERY (2020)
Developments in predictive biomarkers for hepatocellular carcinoma therapy
Casadei-Gardini Andrea et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Optimizing curative management of hepatocellular carcinoma
Pierre Nahon et al.
LIVER INTERNATIONAL (2020)
A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma
Wen Chen et al.
HPB (2020)
Transarterial radioembolization with Yttrium-90: current status and future prospects
Hua-Yu Yang et al.
GASTROENTEROLOGY REPORT (2020)
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
Liang-He Lu et al.
CANCER MEDICINE (2020)
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
Stephen P. Hack et al.
FUTURE ONCOLOGY (2020)
Identification of Platform-Independent Diagnostic Biomarker Panel for Hepatocellular Carcinoma Using Large-Scale Transcriptomics Data
Harpreet Kaur et al.
FRONTIERS IN GENETICS (2020)
Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients
Dan G. Duda et al.
CANCERS (2020)
Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma
Xiao-Lu Ma et al.
FRONTIERS IN ONCOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: A systematic review and meta-analysis
Yuelong Liang et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers
Yuji Eso et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
Marina Barcena-Varela et al.
HEPATOLOGY (2019)
Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion
Ya-Peng Qi et al.
AMERICAN JOURNAL OF SURGERY (2019)
Systematic review of treatment strategy for recurrent hepatocellular carcinoma Salvage liver transplantation or curative locoregional therapy
Hong-Liang Wang et al.
MEDICINE (2019)
Combination of Mac-2 Binding Protein Glycosylation Isomer and Up-To-Seven Criteria as a Useful Predictor for Child-Pugh Grade Deterioration after Transarterial Chemoembolization for Hepatocellular Carcinoma
Yuji Eso et al.
CANCERS (2019)
Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections
Manjiang Li et al.
EJSO (2019)
Adjuvant Treatment of Hepatocellular Carcinoma: Prospect of Immunotherapy
Zachary J. Brown et al.
HEPATOLOGY (2019)
Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
Hongzhi Liu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Clifford Akateh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Kostandinos Sideras et al.
SCIENTIFIC REPORTS (2019)
Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019
Francesco Tovoli et al.
DIGESTIVE AND LIVER DISEASE (2019)
Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis
Mrudula B. Glassberg et al.
ONCOTARGETS AND THERAPY (2019)
Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC
Xieling Yin et al.
TRANSLATIONAL CANCER RESEARCH (2019)
Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need
Yasunori Minami et al.
HEPATOBILIARY SURGERY AND NUTRITION (2019)
Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
Sang Yun Ha et al.
SCIENTIFIC REPORTS (2019)
Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection
Kun-Ming Chan et al.
BIOMEDICAL JOURNAL (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma
Xiao-Lu Ma et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification
Minjong Lee et al.
GUT AND LIVER (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem et al.
HEPATOLOGY (2018)
Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization
Yutaka Yasui et al.
HEPATOLOGY RESEARCH (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis
Ka Wing Ma et al.
LIVER TRANSPLANTATION (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radlotrequency Ablation
Zhenwei Peng et al.
RADIOLOGY (2018)
Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
Francesco Vasuri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
Jinsoo Rhu et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2018)
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus
Tianfu Wen et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
Xinping Ye et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The current role of laparoscopic resection for HCC: a systematic review of past ten years
Stefano Di Sandro et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
Wei Wei et al.
CANCER COMMUNICATIONS (2018)
Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma
Shenghua Hao et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy
Tyler D. Fields et al.
WORLD JOURNAL OF SURGERY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis
Alessandro Granito et al.
LANCET ONCOLOGY (2017)
Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis
Mingheng Liao et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2017)
Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study
Kairui Liu et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)
Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma
Xiaomeng Dai et al.
TRANSLATIONAL ONCOLOGY (2017)
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
Jia-Zhou Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence
Wei Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy
Sheng-lan Yang et al.
HPB (2017)
Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection
Wei-Chi Sun et al.
ONCOTARGET (2017)
Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis
Yifan Tong et al.
ONCOTARGET (2017)
Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation
Yuhua Shan et al.
SCIENTIFIC REPORTS (2017)
VEGF overexpression predicts poor survival in hepatocellular carcinoma
Sae Byeol Choi et al.
OPEN MEDICINE (2017)
Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma
S. Erridge et al.
BRITISH JOURNAL OF SURGERY (2017)
When Should We Propose Liver Transplant After Resection of Hepatocellular Carcinoma? A Comparison of Salvage and De Principe Strategies
Ecoline Tribillon et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2
Chen-Chun Lin et al.
LIVER CANCER (2016)
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
Prashant Bhangui et al.
ANNALS OF SURGERY (2016)
Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence
Wing Chiu Dai et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features
Julien Calderaro et al.
HEPATOLOGY (2016)
Prospective Validation of Ab Initio Liver Transplantation in Hepatocellular Carcinoma Upon Detection of Risk Factors for Recurrence After Resection
Joana Ferrer-Fabrega et al.
HEPATOLOGY (2016)
Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials
Tengfei Si et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
Chen Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view
Jung Yeon Lee et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2016)
Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma
Jie Zhang et al.
CHINESE JOURNAL OF CANCER (2016)
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
Po-Chih Yang et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Chemoembolization of Recurrent Hepatoma After Curative Resection: Prognostic Factors
Qing-Quan Zu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis
Parissa Tabrizian et al.
ANNALS OF SURGERY (2015)
Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis
Di-Ya Wang et al.
Asian Pacific Journal of Cancer Prevention (2015)
Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy
Liming Wang et al.
CANCER BIOLOGY & THERAPY (2015)
Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: A prospective cohort study
K. Wang et al.
EJSO (2015)
Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern
Xiaoyun Zhang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Nicolas Pote et al.
JOURNAL OF HEPATOLOGY (2015)
Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis
Xuxiao Chen et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Hepatocellular Carcinoma: Surveillance CT Schedule after Hepatectomy Based on Risk Stratification
Dan Liu et al.
RADIOLOGY (2015)
Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study
Kyoung Doo Song et al.
RADIOLOGY (2015)
Recurrent hepatocellular carcinoma: A Western strategy that emphasizes the impact of pathologic profile of the first resection
Roberto L. Meniconi et al.
SURGERY (2015)
Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy
Yusuke Yamamoto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Ablation for Recurrent Hepatocellular Carcinoma: A Systematic Review of Clinical Efficacy and Prognostic Factors
S. C. Thomasset et al.
WORLD JOURNAL OF SURGERY (2015)
Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
Xingshun Qi et al.
ONCOTARGET (2015)
Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
Decai Yu et al.
ONCOTARGET (2015)
Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy
Ryoji Hashimoto et al.
ONCOLOGY LETTERS (2015)
Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma
Laurence Lacaze et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Treatment Options and Surveillance Strategies After Therapy for Hepatocellular Carcinoma
Ioannis Hatzaras et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion
Young-Joo Jin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Results of salvage liver transplantation
Gian Piero Guerrini et al.
LIVER INTERNATIONAL (2014)
Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma
Dai Shimizu et al.
ONCOLOGY REPORTS (2014)
Living-Donor Liver Transplantation Associated With Higher Incidence of Hepatocellular Carcinoma Recurrence Than Deceased-Donor Liver Transplantation
Min-Su Park et al.
TRANSPLANTATION (2014)
Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma
Albert C. Y. Chan et al.
WORLD JOURNAL OF SURGERY (2014)
Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma A Retrospective Analysis
Yohei Mano et al.
ANNALS OF SURGERY (2013)
Treatment strategy for recurrent hepatocellular carcinoma: Salvage transplantation, repeated resection, or radiofrequency ablation?
Albert C. Y. Chan et al.
LIVER TRANSPLANTATION (2013)
Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection
Shun-Jun Fu et al.
SURGERY (2013)
Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular carcinoma - A systematic review
Daniel L. Chan et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China
Zhi-yong Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
Recipient outcomes of salvage liver transplantation versus primary liver transplantation: A systematic review and meta-analysis
Zhenhua Hu et al.
LIVER TRANSPLANTATION (2012)
Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
Fei Liu et al.
PLOS ONE (2012)
Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial
Zhen-Wei Peng et al.
RADIOLOGY (2012)
Salvage liver transplantation in the treatment of hepatocellular carcinoma: A Meta-analysis
Hong-Yu Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
Albert C. Y. Chan et al.
WORLD JOURNAL OF SURGERY (2012)
FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria
Hongcheng Sun et al.
CANCER LETTERS (2011)
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma
Jun Cheng et al.
CANCER LETTERS (2011)
Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma
Kevin Tak-Pan Ng et al.
EUROPEAN JOURNAL OF CANCER (2011)
Prevention of Recurrence After Resection of Hepatocellular Carcinoma: A Daunting Challenge
Ronnie T. P. Poon
HEPATOLOGY (2011)
Repeated liver resection for recurrent hepatocellular carcinoma
Wladimir Faber et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma
Ray-Hwang Yuan et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria
Wolfgang Sieghart et al.
JOURNAL OF HEPATOLOGY (2011)
Second hepatic resection for recurrent hepatocellular cancer: A Western experience
Sasan Roayaie et al.
JOURNAL OF HEPATOLOGY (2011)
MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
Fumiaki Sato et al.
PLOS ONE (2011)
Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: Prognosis and outcomes
Tan To Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review
Yanming Zhou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Differentiating Early and Late Recurrences After Resection of HCC in Cirrhotic Patients: Implications on Surveillance, Prevention, and Treatment Strategies
Ronnie T. P. Poon
ANNALS OF SURGICAL ONCOLOGY (2009)
Second and third hepatectomies for recurrent hepatocellular carcinoma are justified
C. -C. Wu et al.
BRITISH JOURNAL OF SURGERY (2009)
Wnt-1 Protein as a Prognostic Biomarker for Hepatitis B-Related and Hepatitis C-Related Hepatocellular Carcinoma after Surgery
Hao-Hsien Lee et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Xin-Rong Yang et al.
CLINICAL CANCER RESEARCH (2009)
A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma
Sasan Roayaie et al.
GASTROENTEROLOGY (2009)
Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment
Wei Yang et al.
HEPATOLOGY RESEARCH (2009)
Living Donor Liver Transplantation for Hepatocellular Carcinoma: Increased Recurrence but Improved Survival
Khashayar Vakili et al.
LIVER TRANSPLANTATION (2009)
Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma After Liver Resection: Feasibility of the Milan Criteria and Operative Risk
B. -W. Kim et al.
TRANSPLANTATION PROCEEDINGS (2008)
Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: Long-term follow-up results and prognostic factors
Dongil Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shimul A. Shah et al.
SURGERY (2007)
Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: Therapeutic efficacy on early- and late-phase recurrence
W Yang et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Early and late recurrence after liver resection for hepatocellular carcinoma - Prognostic and therapeutic implications
N Portolani et al.
ANNALS OF SURGERY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Up-regulation of vascular endothelial growth factor (VEGF) in small-for-size liver grafts enhances macrophage activities through VEGF receptor 2-dependent pathway
ZF Yang et al.
JOURNAL OF IMMUNOLOGY (2004)
Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis
IOL Ng et al.
JOURNAL OF PATHOLOGY (2003)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
RTP Poon et al.
ANNALS OF SURGERY (2000)
Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
PE Majno et al.
HEPATOLOGY (2000)
分享论文
